Cquin Tablet

About Cquin 250 mg Tablet

Cquin comes as a tablet with 250 mg of Chloroquine Phosphate, from Opsonin Pharma Limited. Do not use it for any other purpose without medical advice.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Cquin 250 mg Tablet?

Cquin 250 mg is a tablet product of Opsonin Pharma Limited that contains Chloroquine Phosphate. Chloroquine works against the malaria parasite in the blood and has effects in other conditions. Use it only as your doctor directs.

Uses of Cquin

Do not use it for any other purpose without medical advice. It is also used in the treatment of amoebic hepatitis and amoebic liver abscess, and in some inflammatory conditions such as discoid and systemic lupus erythematosus and rheumatoid arthritis. Ask your doctor or pharmacist if you are unsure why it has been prescribed for you.

How to use Cquin

Swallow the tablet with water, and try to take it at the same time each day if your doctor advises. Cquin is taken by mouth. The doctor decides the dose, how often to take it and how long the course lasts; do not change these yourself. Do not change the dose or stop the course on your own; ask your doctor or pharmacist if anything is unclear.

Side effects of Cquin

Rarely, blood disorders like low platelets or anaemia have been reported. With prolonged use or higher doses, side effects can be more serious: skin rashes, hair loss, changes in skin colour, difficulty focusing the eyes or blurred vision. Some people may get headache or stomach upset such as nausea or loose stools. Tell your doctor about any side effect. Contact your doctor if you notice any side effects.

Safety and precautions

Long-term use requires regular eye check-ups. Patients on long-term or high-dose therapy or frequent prophylaxis may need regular eye examinations as advised by the doctor. Before taking Cquin 250 mg tablet, tell your doctor about all your medical conditions, especially porphyria with liver dysfunction or cirrhosis, as the drug may worsen symptoms. Ask your doctor before starting this medicine if you have any health conditions.

Frequently asked questions

What does Cquin treat?

Do not use it for any other purpose without medical advice. It is also used in the treatment of amoebic hepatitis and amoebic liver abscess, and in some inflammatory conditions such as discoid and systemic lupus erythematosus and rheumatoid arthritis.

How do I use Cquin correctly?

Swallow the tablet with water, and try to take it at the same time each day if your doctor advises. Cquin is taken by mouth.

What are the side effects of Cquin?

Rarely, blood disorders like low platelets or anaemia have been reported. With prolonged use or higher doses, side effects can be more serious: skin rashes, hair loss, changes in skin colour, difficulty focusing the eyes or blurred vision.

Who should be careful with Cquin?

Long-term use requires regular eye check-ups. Patients on long-term or high-dose therapy or frequent prophylaxis may need regular eye examinations as advised by the doctor.

Also available as

80 mg/5 ml (Syrup)

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.